[Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].

Weize Fan, Xianghua Fu, Yunfa Jiang, Xinshun Gu, Weili Wu, Shiqiang Li, Jun Liu, Ling Xue, W. Yongyun, Guozhen HaoPubMed 2007

Abstract

Intracoronary administration of anisodamine is safe and could partly attenuate the no-reflow phenomenon, improve the left ventricular systolic function and synchrony and reduce the incidence of MACE in patients with no-reflow phenomenon post AMI-PCI.
BibTeX
@inproceedings{fan2007influence,
  author = {Weize Fan and Xianghua Fu and Yunfa Jiang and Xinshun Gu and Weili Wu and Shiqiang Li and Jun Liu and Ling Xue and W. Yongyun and Guozhen Hao},
  title = {{[Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].}},
  booktitle = {PubMed},
  year = {2007},
}

Loading related content...

Figure